An Open Study To Estimate The Plasma Pharmacokinetics Of PF-00241939 Administered Via Oral Inhalation Using Dry Powder Inhalers.

Next Previous
Trial Profile

An Open Study To Estimate The Plasma Pharmacokinetics Of PF-00241939 Administered Via Oral Inhalation Using Dry Powder Inhalers.

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Jan 2011

At a glance

  • Drugs PF 241939 (Primary)
  • Indications Asthma
  • Focus Pharmacokinetics

    • Most Recent Events

    • 21 Jan 2011 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
    • 21 Jan 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
    • 21 Jan 2011 Actual initiation date (Oct 2010) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top